e-learning
resources
Munich 2006
Sunday 03.09.2006
New aspects in the pathogenesis of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of neutrophils in the asthmatic late-phase response in humans. Evidence for a non-specific bronchoalveolar inflammatory response
A. Behrendt, M. Foerster, D. Haefner, C. Kroegel (Jena, Pfronten-Ried, Germany)
Source:
Annual Congress 2006 - New aspects in the pathogenesis of asthma
Session:
New aspects in the pathogenesis of asthma
Session type:
Thematic Poster Session
Number:
1393
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Behrendt, M. Foerster, D. Haefner, C. Kroegel (Jena, Pfronten-Ried, Germany). The role of neutrophils in the asthmatic late-phase response in humans. Evidence for a non-specific bronchoalveolar inflammatory response. Eur Respir J 2006; 28: Suppl. 50, 1393
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001
CCL6 produced by eosinophils drives allergic airway inflammation in mice
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
The role of ACN9 in the inflammatory response in the airway
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
IL-33/sST2 balance regulates neutrophilic inflammation in the human airways.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
Dose-dependent differences of allergic challenge in airway reactivity and BAL cell response
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Dividing neutrophils in subsets, reveals a significant role for CD16highCD62Ldim neutrophils in the development of airway hyperreactivity
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
The role of MKK3 in allergic and non-allergic inflammatory responses in the lung
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
LSC Abstract – Changes of peripheral blood eosinophil activity during allergen-induced late-phase airway inflammation in asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
γδ T cells contribute to local and systemic B cell reactivity in allergic eosinophilic airway inflammation but without a major influence on the TH1/TH2 balance
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
A role for Th1 cells in airway remodeling and hyperreactivity in mice subjected to chronic allergen exposure
Source: Eur Respir J 2007; 30: Suppl. 51, 734s
Year: 2007
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept